IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease-Reference-Cited by-同舟云学术

IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease

Published:2022-06-15 Issue:12 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Dwyer Gaelen K.^ORCID,Mathews Lisa R.,Villegas José A.,Lucas Anna,Gonzalez de Peredo Anne,Blazar Bruce R.^ORCID,Girard Jean-Philippe,Poholek Amanda C.^ORCID,Luther Sanjiv A.^ORCID,Shlomchik Warren,Turnquist Hēth R.^ORCID

Funder

NIH

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/150927/files/pdf

Reference91 articles.

1. Ex Vivo T Cell–Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission

2. Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts

3. Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies

4. Current Concepts and Advances in Graft-Versus-Host Disease Immunology

5. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation;Nature Communications;2024-07-17

2. Extracellular release of damaged mitochondria induced by prehematopoietic stem cell transplant conditioning exacerbates GVHD;Blood Advances;2024-07-11

3. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01

4. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

5. Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?;Pharmaceuticals;2024-02-26